Vice President, Drug Safety and Pharmacovigilance

Company:

At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body brain and eye. Our novel scientific approach targets upstream C1q to block the classical complement inflammatory cascade before it starts and its therapeutic candidates are designed to provide meaningful benefits across multiple autoimmune neurodegenerative and ophthalmic diseases. With proof-of concept data in Guillain-Barré syndrome Huntingtons disease and geographic atrophy we are rigorously advancing our mid-to late-stage clinical trials to bring new potential treatments to patients as quickly as possible. At Annexon youll be part of a team committed to making an impact together.

For more information on Annexon and our pipeline check out our site Annexon Biosciences & Annexon Pipeline. We trade on Nasdaq under the ticker symbol ANNX and are headquartered in Brisbane CA.

Were seekingexceptional talent from all backgrounds to fuel our growth. At Annexon were building a diverse equitable and inclusive workplace. We value unique perspectives and unconventional paths. If youre the best candidate for the job even if you dont perfectly fit the traditional mold we encourage you to more about our commitment to diversity equity inclusion and our companyculture!

Position:

Reporting into the SVP Regulatory the Vice President Drug Safety and Pharmacovigilance will be responsible for overseeing and directing Annexons portfolio of investigational compounds; building the department function and actively participating in the oversight of patient safety in all clinical trials. The successful candidate will be responsible for executing short-term objectives while developing a long-term vision and strategy for monitoring and protecting the safety of patients receiving Annexons novel therapies.

Responsibilities include:

• Ensure PV Medical Safety activities are performed in compliance with all applicable regulations and Annexon standards.
• Collaborate with members of the clinical development team in the development and implementation of clinical protocols safety management plans data monitoring committee charters informed consent form (ICF) risk template language and safety events
• Manages internal employees external contractors and vendors to ensure delivery of quality drug safety and PV activities; selects develops trains and evaluates team to ensure the efficient operation of the drug safety function.
• Medical safety lead on cross-functional study and program teams for assigned products and studies providing expert guidance regarding safety matters and issues.
• Provide support for safety sections of clinical documents including the review and approval of the safety portion of protocols informed consent forms final study reports IB/RSI and other documents.
• Provide timely and sound medical review of individual case safety reports from clinical trials or post-marketing sources as needed.
• Lead the regular review of safety data for assigned products for the identification of new safety signals in accordance with signal detection practices
• Assess safety signals and trends and proactively manage any potential safety issues.
• Lead development of Risk Management Plans implementation and evaluation of their
• Ensure safety issues are communicated to the appropriate stakeholders in a timely
• Author analysis of similar events (AOSE) and individual case comments for
• Accountable for medical evaluation/interpretation of aggregate safety data of assigned product(s) including signal detection and evaluation aggregate reports (DSUR PADER PBRER/PSUR) and ad hoc safety assessments.
• Maintain knowledge of global regulatory authority regulations including FDA and
• Formulate response strategies for safety-related health authority and ethics committee
• Represent PV in communications with health authorities such as the FDA and EMA.
• Provide guidance to staff regarding optimal practice regarding collection evaluation and processing of adverse experience reports from a medical perspective.
• Other duties assigned.

Education Experience and Skills:

Required:

• MD MBBS DO degree with clinical post-training is required
• A minimum of 10 years of relevant drug safety and/or clinical research/clinical safety experience in the biotechnology/pharmaceutical/CRO industry including safety leadership
• Thorough understanding of global pharmacovigilance regulations GCP & ICH
• Ability to create and fulfill a vision in a matrix environment and work collaboratively with internal stakeholders across different functions
• Neurodegenerative disease autoimmune and/or ophthalmology expertise is a
• Working knowledge of validated drug safety databases and dictionaries (Argus MedDRA etc.)
• Extensive knowledge of all types of aggregate safety
• In-depth understanding of the drug development

Salary Range: 362700 - 403000

Location:Annexon Biosciences is located in Brisbane California and preference is given to candidates in the San Francisco Bay Area.

Benefits:

• A stimulating and rewarding workplace includes flexible work schedules remote opportunities and the ability to achieve a work-life balance.
• Shuttle service from BART CalTrain and the Ferry.
• Annexon offers a competitive base salary and equity participation employee stock purchase plan as well as a comprehensive health benefit package that includes medical dental vision 401(k) flexible spending plans and other benefits.

Annexon Biosciences is an Equal Opportunity Employer and we prohibit discrimination or harassment of any kind. We are committed to fostering an environment where ALL people are welcome and supported. We cultivate a culture of inclusion for all employees that respects their individual strengths views and experiences. We believe that our differences enable us to be a better team one that makes better decisions drives innovation and delivers better business results. Creativity and innovation flourish in an environment of openness inclusion and mutual respect.